Previous 10 | Next 10 |
2024-02-02 14:54:54 ET More on Neximmune Financial information for Neximmune Read the full article on Seeking Alpha For further details see: NexImmune slips after securities offering
GAITHERSBURG, Md., Feb. 02, 2024 (GLOBE NEWSWIRE) -- NexImmune, Inc. a biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells in oncology, autoimmune and infectious diseases, today...
2024-02-01 10:00:10 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Investors were most bullish on H...
2024-02-01 08:29:22 ET More on pre-market losers & stocks. Bullfrog AI stock rallies 32% on early brain research results Infobird announces new business deal in software development of information technology system Financial information for Bullfrog AI Holdings, ...
2024-01-31 08:24:06 ET Guardion Health Sciences ( GHSI ) +84% Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv Brand and Business to Doctor’s Best Inc Ensysce Biosciences ( ENSC ) +33% Announces Positive End of Phase 2 M...
2024-01-30 11:50:46 ET Gainers: Neximmune ( NEXI ) +163% . Pixelworks ( PXLW ) +47% . PepGen ( PEPG ) +37% . Rail Vision Ltd ( RVSN ) +36% . Bit Origin Ltd ( BTOG ) +34% . Vivos Therapeutics ( VVOS ) +32% . GRI Bi...
2024-01-30 10:56:41 ET DENVER, Colo., Jan. 30, 2023 ( www.247marketnews.com )- NexImmune (NASDAQ: NEXI) is trading at $18.33, up $9.03 (+97.10%), on 6.3M shares traded. Its 52-week range is $1.2501 to $20.70. It hit a new 52-week low, late November, rallied, and almost broke its 52-...
2024-01-30 08:30:28 ET More on Pre-market losers & stocks. Borr Drilling: Still Undervalued, But The Easy Money Has Already Been Made Borr Drilling: Jackup Market Expected To Remain Strong - Buy Borr Drilling Limited (BORR) Q3 2023 Earnings Call Transcript ...
2024-01-29 13:21:09 ET Gainers: Neximmune ( NEXI ) +94% . Palisade Bio PALI +83% . Rail Vision Ltd ( RVSN ) +68% . Revelation Biosciences ( REVB ) +54% . Mercurity Fintech Holding MFH +34% . J-Long Group Ltd JL +29% . Intelli...
2024-01-29 08:28:44 ET Revelation Biosciences ( REVB ) +69% . TuanChe ( TC ) +38% . Spectral AI ( MDAI ) +38% . Hub Cyber Security ( HUBC ) +34% . Cadrenal Therapeutics ( CVKD ) +14% . J-Long Group ( JL ...
News, Short Squeeze, Breakout and More Instantly...
NexImmune Inc. Company Name:
NEXI Stock Symbol:
NASDAQ Market:
Inpixon (INPXV) is expected to report for Q1 2024 Siebert Financial Corp. (SIEB) is expected to report for Q1 2024 Greenwave Technology Solutions Inc. (GWAV) is expected to report for Q1 2024 Bank Hapoalim B.M. ADR (BKHYY) is expected to report for Q1 2024 Gelesis Holdings, Inc. (...
Revenues at € 781.6 million in 1Q24, +6.0% Y/Y EBITDA at € 361.7 million in 1Q24, +8.6% Y/Y, with c. +112 bps EBITDA margin expansion 2024 Guidance confirmed Up to € 500 million share buy-back program launched today Th...
Rome becomes the first European city to offer open loop transit payments to JCB Cardmembers TOKYO & LONDON, May 8, 2024 - (JCN Newswire) - Boarding public transport and pay the fare by simply tapping with a contactless payment card on turnstiles or authorized readers: Rome is th...